Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This is a trial of Regorafenib in combination with pembrolizumab for patients with MSI-H colorectal cancer consisting of lead-in phase examining preliminary efficacy and safety, followed by a randomized phase to further examine efficacy.
创建时间：
2023-08-15
